In patients with hepatocellular carcinoma (HCC) who received immunotherapy, median overall survival was 20.6 months in those with preserved liver function. Metabolic dysfunction-associated steatotic ...
Jay N. Yepuri, MD, MS, FACG, is a board-certified gastroenterologist and member of the Digestive Health Associates of Texas Board of Directors and Executive Committee. A liver function test checks how ...